Issue 1/2020
Content (14 Articles)
Therapy resistance/chronicity, their determinants and potential solutions
Hans-Jürgen Möller
Use of benzodiazepines and z-drugs not compliant with guidelines and associated factors: a population-based study
Arnaud Panes, Antoine Pariente, Anne Bénard-Laribière, Régis Lassalle, Caroline Dureau-Pournin, Simon Lorrain, Marie Tournier, Annie Fourrier-Réglat
Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study
Parita Shah, Yusuke Iwata, Eric E. Brown, Julia Kim, Marcos Sanches, Hiroyoshi Takeuchi, Shinichiro Nakajima, Margaret Hahn, Gary Remington, Philip Gerretsen, Ariel Graff-Guerrero
Neuroleptic malignant syndrome: evaluation of drug safety data from the AMSP program during 1993–2015
Michael Schneider, Johannes Regente, Timo Greiner, Stephanie Lensky, Stefan Bleich, Sermin Toto, Renate Grohmann, Susanne Stübner, Martin Heinze
Severe parkinsonism under treatment with antipsychotic drugs
Katrin Druschky, Stefan Bleich, Renate Grohmann, Rolf R. Engel, Sermin Toto, Alexandra Neyazi, Barbara Däubl, Susanne Stübner
Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients
Priyanthi B. Gjerde, Carmen E. Simonsen, Trine V. Lagerberg, Nils E. Steen, Torill Ueland, Ole A. Andreassen, Vidar M. Steen, Ingrid Melle
Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosis
Liisa Leppik, Madis Parksepp, Sven Janno, Kati Koido, Liina Haring, Eero Vasar, Mihkel Zilmer
Phenoconversion of CYP2D6 by inhibitors modifies aripiprazole exposure
Ádám Kiss, Ádám Menus, Katalin Tóth, Máté Déri, Dávid Sirok, Evelyn Gabri, Ales Belic, Gábor Csukly, István Bitter, Katalin Monostory
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design
Christian Schmidt-Kraepelin, Sandra Feyerabend, Christina Engelke, Mathias Riesbeck, Eva Meisenzahl-Lechner, Wolfgang Gaebel, Pablo-Emilio Verde, Henrike Kolbe, Christoph U. Correll, Stefan Leucht, Stephan Heres, Michael Kluge, Christian Makiol, Andrea Neff, Christina Lange, Susanne Englisch, Mathias Zink, Berthold Langguth, Timm Poeppl, Dirk Reske, Euphrosyne Gouzoulis-Mayfrank, Gerhard Gründer, Alkomiet Hasan, Anke Brockhaus-Dumke, Markus Jäger, Jessica Baumgärtner, Thomas Wobrock, Joachim Cordes
Mental health in refugees and asylum seekers (MEHIRA): study design and methodology of a prospective multicentre randomized controlled trail investigating the effects of a stepped and collaborative care model
Kerem Böge, Carine Karnouk, Eric Hahn, Frank Schneider, Ute Habel, Tobias Banaschewski, Andreas Meyer-Lindenberg, Hans Joachim Salize, Inge Kamp-Becker, Frank Padberg, Alkomiet Hasan, Peter Falkai, Michael A. Rapp, Paul L. Plener, Thomas Stamm, Nehal Elnahrawy, Klaus Lieb, Andreas Heinz, Malek Bajbouj
Pharmacotherapy of psychiatric inpatients with adjustment disorder: current status and changes between 2000 and 2016
Timo Greiner, Beatrice Haack, Sermin Toto, Stefan Bleich, Renate Grohmann, Frank Faltraco, Martin Heinze, Michael Schneider
Inhibition of monoamine oxidase activity by repetitive transcranial magnetic stimulation: implications for inter-train interval and frequency
Michael Kaczmarczyk, Francesca Regen, Isabella Heuser, Malek Bajbouj, Julian Hellmann-Regen
A proteomic signature associated to atypical antipsychotic response in schizophrenia patients: a pilot study
Daniel Martins-de-Souza, Paul C. Guest, Johann Steiner
Cannabidiol: a hope to treat non-motor symptoms of Parkinson's disease patients
Sidra Saleem, Arsalan Anwar